{
  "chunk_id": "BỆNH PELLAGRA_12",
  "disease": "BỆNH PELLAGRA",
  "section": "OVERVIEW",
  "file_name": "PELLAGRA.txt",
  "content": "53. Genodermatoses and Congenital Anomalies. In: James WD, Berger TG, Elston DM, eds (2011). Andrews' Diseases of the Skin: Clinical Dermatology. 11th ed. Philadelphia, Pa: Saunders Elsevier; chap 27.\n54. Geria AN, Schuartz RA (2010). Impetigo Update: New Challenges in the Era of Methicillin Resistance. Cutis. 85(2).p.65-70.\n55. Goodfi M.J.D., Jones S.K., Veales D.J. (2010). The connective tissue diseases. Rook’s textbook of dermatology.\n56. Goutagny, S; Kalamarides, M (September 2010). Meningiomas and neurofibromatosis. Journal of neuro-oncology 99(3).p.341–7.\n57. Gulliver W (2008). Long-term prognosis in patients with psoriasis. Br J Dermatol. 159(2).pp.2-9.\n58. Halevy S, Ghislain PD, Mockenhaupt M, et al. (2008). Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 58(1).pp.25-32.\n59. Hay R.J., Adriaans B.M. (2010). Bacterial infections. Rook’s textbook of dermatology.\n60. Hay RJ (2009). Scabies and pyodermas--diagnosis and treatment. Dermatol Ther. 22(6).pp.466-474.\n61. Hershko AY, Suzuki R, Charles N, et al. (2011). Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity. 35(4).pp.562-571.\n62. Hicks MI, Elston DM. Scabies. Dermatol Ther. 22(4).pp.279-292.\n63. Hsu LY, Wijaya L, Shu-Ting Ng E, Gotuzzo E (2012). Tropical fungal infections. Infect Dis Clin North Am. 26(2).pp.497-512.\n64. Iseman M.D. (2002). Tuberculosis therapy, Past, present and Future. Eur, Respir J, Suppl. 36. pp.87.\n65. J.J Grob et al (2001). Mélanome cutané. Thérapeutique dermatologique. p. 527-23.\n66. James G. Marks Jr et al. (2002). Contact and Occupational Dermatology. 3rd edn, Mosby Elsevier. American.\n67. James, William, Berger, Timothy, Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders."
}